| Date Filed | Type | Description |
| 07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/31/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Bought 800,000 shares
@ $27, valued at
$21.6M
|
|
| 01/28/2022 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Exercised (in-or-at-the-money) 75,749 options to buy
@ $13.2, valued at
$999.9k
Exercised (in-or-at-the-money) 1,455,384 options to buy
@ $13.2, valued at
$19.2M
Exercised (in-or-at-the-money) 324,740 options to buy
@ $13.2, valued at
$4.3M
|
|
| 11/01/2021 |
SC 13G
| VIVO VENTURES VII, LLC reports a 7.8% stake in Minerva Surgical, Inc. |
| 01/31/2020 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on Sierra Oncology, Inc.|
Txns:
| Converted 75,759 shares
@ $0
Converted 1,455,576 shares
@ $0
Converted 324,783 shares
@ $0
Converted 1,000 options to buy
@ $0
Converted 19,213 options to buy
@ $0
Converted 4,287 options to buy
@ $0 |
|
| 12/02/2019 |
3
| Vivo Opportunity, LLC (10% Owner) has filed a Form 3 on Sierra Oncology, Inc. |
| 10/23/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/14/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/31/2018 |
4
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 4 on AIRXPANDERS INC|
Txns:
| Bought 19,712,492 shares
@ $0.1672, valued at
$3.3M
Bought 429,631 shares
@ $0.1672, valued at
$71.8k
|
|
| 08/31/2018 |
3
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 3 on AIRXPANDERS INC |
| 03/02/2018 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 11/16/2017 |
SC 13D/A
| VIVO VENTURES VII, LLC has filed a Schedule 13D for Aclaris Therapeutics, Inc. |
| 10/20/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/25/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 09/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/14/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/10/2017 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 03/03/2017 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 03/02/2017 |
4
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 195,734 shares
@ $30.5, valued at
$6M
Sold 4,266 shares
@ $30.5, valued at
$130.1k
Sold 97,867 shares
@ $30.98, valued at
$3M
Sold 2,133 shares
@ $30.98, valued at
$66.1k
Sold 122,334 shares
@ $31.2, valued at
$3.8M
Sold 2,666 shares
@ $31.2, valued at
$83.2k
|
|
| 02/13/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 11/21/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/18/2016 |
4
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 448,063 shares
@ $23.25, valued at
$10.4M
Sold 9,765 shares
@ $27.3, valued at
$266.6k
Sold 440,402 shares
@ $22.72, valued at
$10M
Sold 9,598 shares
@ $22.72, valued at
$218.1k
|
|
| 09/12/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 08/17/2016 |
4
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 4 on CODEXIS INC|
Txns:
| Sold 48,934 shares
@ $4.274, valued at
$209.1k
Sold 36,107 shares
@ $4.2072, valued at
$151.9k
Sold 1,066 shares
@ $4.274, valued at
$4.6k
Sold 787 shares
@ $4.2072, valued at
$3.3k
|
|
| 08/05/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/20/2016 |
SC 13D/A
| Ascendis Pharma A/S reports a 6.9% stake in Ascendis Pharma A/S |
| 06/03/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 04/22/2016 |
SC 13D/A
| VIVO VENTURES VII, LLC reports a 5% stake in MEI Pharma, Inc. |
| 04/15/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 04/07/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 03/10/2016 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 11/09/2015 |
4
| VIVO VENTURES VII, LLC (10% Owner) has filed a Form 4 on MEI Pharma, Inc.|
Txns:
| Sold 225,660 shares
@ $1.91, valued at
$431k
Sold 7,560 shares
@ $1.85, valued at
$14k
Sold 157,352 shares
@ $1.75, valued at
$275.4k
|
|
|